Axios @axios
Pfizer is seeking emergency use authorization from the FDA for its Omicron-specific booster for children ages 5-11. Moderna made the same request for its booster for ages 6-17 on Friday. https://t.co/xhUzgejutG — PolitiTweet.org
Created
Mon Sep 26 13:50:27 +0000 2022
Likes
49
Retweets
18
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Axios @axios
Pfizer is seeking emergency use authorization from the FDA for its Omicron-specific booster for children ages 5-11. Moderna made the same request for its booster for ages 6-17 on Friday. https://t.co/xhUzgejutG — PolitiTweet.org